FutureFuel Corp.

What they do

FutureFuel runs an ISO 9001-accredited chemical plant and a 59 million gallon per year biodiesel facility on the same site, sharing infrastructure between the two. The Chemicals segment makes custom chemicals for a single customer (including cosmetics and personal care products, specialty polymers, chlorinated polyolefin adhesion promoters, antioxidant precursors and a biocide intermediate) plus performance chemicals sold to multiple customers, led by SSIPA/LiSIPA polymer modifiers for nylon and polyester producers. The Biofuels segment produces biodiesel from vegetable oils, animal fats and separated food waste oils, procuring its own feedstock and selling for its own account.

Revenue drivers

• Custom chemicals — Specialty chemicals manufactured for a single customer, including consumer products, chlorinated polyolefin adhesion promoters and antioxidant precursors, and a biocide intermediate; pricing is negotiated directly with the customer and some products have cost pass-through protections.
• Performance chemicals — Specialty chemicals made to general market specifications and sold to a broad customer base, anchored by SSIPA/LiSIPA polymer modifiers used by nylon and polyester fiber manufacturers, plus sulfonated monomers, hydrotropes, specialty solvents, polymer additives and glycerin.
• Biofuels — One product group: biodiesel produced at 59 MMgy capacity, supported by RIN generation (1.5 RINs per gallon, D4 or D6) under the EPA Renewable Fuel Standard, with supplemental revenue from petrodiesel sales and occasional RIN sales.
• Tax credit monetization — On June 30, 2026 the Company contracted with Freepoint Commodities to sell its 2025 CFPC and Small Agri-Biodiesel Producer Tax Credits ($2,725 net of fees) and committed to sell 2026 credits ($6,733 as of June 30, 2026), with 2026-2029 credits monetized at each fiscal year end.

Recent performance

Second quarter 2026 revenue was $78.7 million, up 120.6% from $35.7 million in the prior-year period, with chemical revenue up 55.5% and biofuel revenue up 177.5%. GAAP net income was $11.4 million, or $0.25 per diluted share, versus a net loss of $14.2 million a year earlier, and Adjusted EBITDA was $11.8 million, up more than $23 million. Chemicals gross profit was $5.0 million versus $1.1 million, and biofuels gross profit was $10.1 million versus a gross loss of $13.5 million. Total production rose 26% year-over-year, with chemicals production up 34% and biofuels up 21% despite a more than three-week biodiesel plant outage. Full-year 2025 results were weak by comparison: revenue of $95.7 million and a net loss of $49.4 million.

Strategy

Management describes a dual-track strategy of diversification and vertical integration, including backward integration into key intermediate raw materials to secure internal supply and create a new external sales revenue stream. The Company is investing in process automation and lean methodologies to improve manufacturing reliability and throughput, and is pursuing customer co-investments in new capacity and capabilities within specialty chemical contract manufacturing. In biofuels, the Company is ramping production as regulatory clarity improves, and has secured a four-year agreement to monetize Section 45Z Clean Fuel Production and Small Producer Tax Credits. Capital return continues via dividends: $0.24 per share distributed in 2025 and an initial 2026 quarterly dividend of $0.06 per share declared for the first quarter.

Risks

• Biofuels policy dependence — The biofuels segment depends on federal and state programs including the CFPC (still in proposed rule status) and the RFS, and the expiration or loss of mandates or incentives would have a material adverse effect on the business.
• RIN and credit price uncertainty — Delayed RFS2 renewable volume obligations and EPA changes, including reducing the renewable diesel RIN equivalency factor from 1.7 toward 1.5 by 2027, create uncertainty in the value of each RIN and in renewable fuel market economics.
• Feedstock and input cost volatility — Biofuels results depend on feedstock prices relative to finished biodiesel prices, and the chemicals segment sources certain raw materials internationally, exposing it to supply chain disruption and price inflation.
• Competing fuel and demand shifts — Government incentives favor renewable diesel over biodiesel, and policy shifts and subsidies for electric vehicles could reduce long-term demand for liquid combustion fuels and for RINs and LCFS credits.

Outlook

Management anticipates positive Adjusted EBITDA for full-year 2026, excluding non-cash derivative timing differences related to changes in physical commodity prices, and stated it remains on pace to deliver that result. Third quarter biodiesel production rates are expected to exceed second quarter levels. The Company notes continued uncertainty in future biodiesel production volumes driven by feedstock price volatility and the lack of permanence in critical government mandates.